A comparison was made of disease development in two lines of transgenic mice in which the granulocytemacrophage colony-stimulating factor (GM-CSF) transgene was inserted in different chromosomal locations. Female-line mice (X chromosome insertion) had equivalent elevations of serum GM-CSF levels to those in male-line mice (autosomal insertion) but a shorter survival (median survival, 95 versus 145 days) and a significantly higher incidence of large inflammatory foci in skeletal muscle and gut congestion. Male-line transgenic mice had higher levels of cells in the peritoneal cavity and a higher frequency ofspleen enlargement with excess erythropoiesis than female-line mice and uniquely developed fibrotic nodules in the abdominal and pleural cavities. The various diseases in GM-CSF transgenic mice are likely to have been induced by GM-CSF-stimulated products of macrophages, and in the two transgenic lines the macrophages exhibit characteristic differences in morphology and possibly functional activity.
ABSTRACT
A comparison was made of disease development in two lines of transgenic mice in which the granulocytemacrophage colony-stimulating factor (GM-CSF) transgene was inserted in different chromosomal locations. Female-line mice (X chromosome insertion) had equivalent elevations of serum GM-CSF levels to those in male-line mice (autosomal insertion) but a shorter survival (median survival, 95 versus 145 days) and a significantly higher incidence of large inflammatory foci in skeletal muscle and gut congestion. Male-line transgenic mice had higher levels of cells in the peritoneal cavity and a higher frequency ofspleen enlargement with excess erythropoiesis than female-line mice and uniquely developed fibrotic nodules in the abdominal and pleural cavities. The various diseases in GM-CSF transgenic mice are likely to have been induced by GM-CSF-stimulated products of macrophages, and in the two transgenic lines the macrophages exhibit characteristic differences in morphology and possibly functional activity.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hemopoietic regulator with the ability to stimulate the proliferation in vitro of neutrophilic granulocytes and monocyte-macrophages and, at progressively higher concentrations, the proliferation of eosinophils, megakaryocytes, and some erythroid and multipotential cells (1) . GM-CSF can also stimulate various functional activities of mature granulocytes and macrophages including the production by macrophages of metabolically active products such as interleukin 1 (2) , tumor necrosis factor (3), t-interferon (4) , and plasminogen activator (5) . Injection of GM-CSF in vivo to animals or humans elevates peripheral blood levels of granulocytes, moncytes, and eosinophils and, if injected intraperitoneally, elicits major increases in peritoneal macrophages and their functional activity (6) (7) (8) (9) .
Two lines of GM-CSF transgenic mice have been developed that each bear two copies of the GM-CSF transgene with a Moloney virus long terminal repeat promoter (10) . In the female-derived line, insertion is on the X chromosome, while in the male-derived line, insertion is on an unidentified autosomal chromosome. The present analysis of disease development in the two GM-CSF transgenic lines has revealed marked differences in the occurrence of various lesions, which, in view of the similar GM-CSF levels in the two lines, suggest that the transgene insertion site influences the pathological consequences of excess GM-CSF levels.
MATERIALS AND METHODS GM-CSF Transgenic Mice. The production and maintenance of the two transgenic lines have been described (10) .
The lines were developed and held under specific pathogenfree conditions. The original eggs injected were (C57BL x SJL)F2 and the transgenic lines were maintained by breeding male or female transgenic mice with normal (C57BL x SJL)F1 mice. All transgenic mice develop ocular opacity and can be classified unambiguously at weaning.
Observations. Mice were either killed at various ages >2 months when in apparent good health (survey mice) or were killed when moribund. Sera were collected and GM-CSF levels were determined by using the GM-CSF-responsive FDC-P1 cell line in microwell assays (1) . These values were converted to bone marrow units/ml by use of GM-CSF standards with known colony-stimulating activity in all assays (50 units is the concentration stimulating half-maximal colony formation in 1-ml agar cultures of 75,000 C57BL marrow cells). Total and differential cell counts were done on peritoneal, pleural, femur, and spleen populations (10) , and histological sections were prepared from all major organs. The data were collected from unselected mice, but not all observations were performed on all mice and different numbers of mice are recorded for various observation parameters.
RESULTS
Mortality in Transgenic Mice. Litter size at weaning in transgenic x normal matings varied from 2 to 14 and was more variable than for control mice (83% of control litters contained 7-10 mice versus 55% for male-line matings and 50% for female-line matings). With male-line matings, approximately equal numbers oftransgenic and normal progeny resulted. Where males of the female line (X chromosomal insertion) were used as mating partners, all female progeny were transgenic. Transgenic mice were in apparent good health until 2 months ofage but the first deaths occurred soon after this age. A survey of 39 female-line and 76 male-line transgenic mice with matching numbers of littermate mice showed that all female-line mice had become moribund by 155 days of age (median survival, 95 days). Male-line mice became moribund at a significantly slower rate (median survival, 145 days), some mice reaching 300 days of age. By this age, only 10% of littermate control mice had died. These differences between the transgenic lines were confirmed in a second study involving 79 female-line mice and 206 male-line mice. No sex difference in mortality rates was observed within each line.
Serum GM-CSF Levels. GM-CSF was detectable in the serum of only 14 of 145 littermate mice. In sharp contrast, high GM-CSF levels were detectable in all but 2 of 503 transgenic mice (Table 1) . Overall, mean serum GM-CSF Abbreviation: GM-CSF, granulocyte-macrophage colony-stimulating factor. *To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. levels in transgenic mice were 50-to 100-fold elevated over mean levels in littermate mice. Serum GM-CSF levels varied over a 15-fold range between individual transgenic mice and while mean levels were slightly lower in female-line mice, particularly when moribund, than in male-line mice, the differences between mice ofthe two lines were not significant statistically. Peritoneal Population Differences Between Transgenic Lines. Adult transgenic mice of both lines showed increased numbers of cells in the peritoneal cavity. While there was considerable variation between individual mice, average total cell numbers and particularly the numbers of macrophages and eosinophils were higher in male-line mice than in femaleline mice (Table 2) . Within lines there were no consistent differences related to age, sex, or clinical status. In individual mice there was no correlation between serum GM-CSF levels and peritoneal cell counts. In neither transgenic line was the morphology of the dominant macrophages normal, but a striking interline difference was observed. In 151 of 181(83%) male-line transgenic mice, the macrophages had round nuclei and bulky pale cytoplasm and 9% + 6% of the cells were bior multinucleate (Fig. 1A) . In contrast, in 54 of 61 (89%) female-line transgenic mice, the macrophages had nuclei with a morphology varying from kidney-shaped to ring-shaped and a relatively narrow rim of basophilic cytoplasm. Few cells were binucleate (3% + 3%) and multinucleate cells were rare (Fig. 1B) . Peritoneal macrophages from all of 44 littermate mice had nuclei of variable morphology resembling those of female-line transgenic mice, but the cells differed in being smaller and lacking the basophilic cytoplasm of female-line transgenic cells.
In 77 of 177 (44%) male-line transgenic mice, some of the peritoneal macrophages contained green-pigmented particulate material, and in 47 of 167 (28%) mice, some macrophages were exhibiting erythrophagocytosis, the erythroid breakdown products possibly being the source of the greenpigmented material in other cells. Neither pigmentation nor erythrophagocytosis was observed in peritoneal macrophages from any of 43 female-line transgenic mice analyzed.
A small volume (0.5-4.0 ml) of ascites fluid was observed in the peritoneal cavity of 34 of 101 (34%) male-line transgenic mice but in only 1 of 24 (4%) female-line mice. The ascites fluid was usually blood stained, the brown-red color indicating chronic rather than recent bleeding. Male-line transgenic mice with ascites had significantly higher total peritoneal cell counts (166 138 x 106 cells) than male-line mice without ascites (80 + 78 x 106) (t = 4.02; P < 0.01), while in the 23 female-line mice lacking ascites the counts were even lower (30 + 30 x 106 cells).
Muscle Lesions. The most frequent clinical appearance of moribund transgenic mice was generalized wasting with muscle tremor and paresis of the hind limbs. Histologically, this was associated with the presence of focal or diffuse cellular infiltration in skeletal muscle (10) . In small foci (Fig.  1C) , the dominant cell type was the macrophage but in larger lesions eosinophils, neutrophils, and sometimes lymphocytes were also present. Adjacent muscle cells were often necrotic, with phagocytosis of their cytoplasm by macrophages, while muscle cells in more distant regions were abnormally thin.
The frequency of mice with large diffuse muscle lesions (Fig. 1D ) was significantly higher in female-line mice than in male-line mice, in which most muscle tissue merely exhibited small focal infiltrations ( Table 3 ). The equal frequency of lesions in healthy and moribund transgenic mice indicated that the lesions were not secondary to the development of terminal paresis from some other cause such as nerve damage.
Gut Congestion. A striking feature of some moribund transgenic mice was the black color of the small bowel and proximal regions of the large bowel (Fig. 1E) . No thrombosis was observed in gut vessels but there was pronounced congestion of small vessels in the villi and often microscopic hemorrhage into the gut lumen. This change was observed in a lower frequency in moribund male-line mice (11 of 112 males, 13 of 132 females) than in moribund female-line mice (6 of 22 males and 25 of 68 females). The difference in frequency of this gut lesion was statistically significant (X2 = 27.2; P < 0.01) when all male-line mice were compared with all female-line mice, the difference being mainly ascribable to the 37% frequency of gut lesions in females of the female line. In individual mice, the occurrence of gut congestion was not correlated with unusual serum GM-CSF levels or peritoneal cell numbers. Abdominal Fibrotic Nodules. Multiple small nodules were observed in the abdominal cavity of 148 of 263 (56%) male-line transgenic mice. These were most often attached to the abdominal surface of the diaphragm (Fig. iF) Male  S  38  87  13  0  Female  S  56  84  16  0  Male-line transgenic  Male  S  31  23  74  3  Female  S  55  55  44  1  Male  M  85  38  58  4  Female   M  89  36  62  2  Female-line transgenic  Male  S  1  0  100  0  Female  S  9  0  22  78  Male  M  12 exhibited an abnormal spleen. Many spleens were atrophic with thickening of the capsule and trabeculae and with atrophy of lymphoid follicles and hemopoietic populations in the red pulp. Atrophy of the spleen was significantly more frequent in moribund female-line mice (41 of 62; 66%) than in moribund male-line mice (71 of 169; 42%; X2 = 9.6; P < 0.01).
Conversely, the spleen in some transgenic mice was enlarged 2-to 4-fold and in such spleens the erythropoietic population was enlhwged and often obliterated the Iymphoid follicles. Excess spleen erythropoiesis was significantly more common in male-line transgenic mice (66 of 247; 27%) than in femaleline transgenic mice (5 of 69; 7%; x2 = 10.7; P < 0.01), the major difference being due to the high frequency of excess erythropoiesis in apparently healthy male-line transgenic mice (34 of 78 mice; 44%). DISCUSSION The abnormalities and disease states exhibited by GM-CSF transgenic mice might in principle be ascribable either to the elevated levels of OM-CSF in these mice or to changes in the activation of other genes as a result of insertion of the GM-CSF transgene in an abnormal chromosomal location. Since the insertion site is different in the two GM-CSF transgenic lines analyzed, common features exhibited by both lines can reasonably be ascribed to direct or indirect effects of excess GM-CSF levels. Conversely, wsvere the lines differ absolutely, an insertional effect appears more (11) . The primary defect in these mice can provisionally be regarded as overproduction of GM-CSF by the transgenic macrophages.
Since GM-CSF is a powerful proliferative and functional stimulus for macrophages and their precursors (1, 2) , the increased numbers of macrophages can reasonably be interpreted as a direct effect of elevated GM-CSF levels. As discussed previously (10, 11) , the development of eye and muscle lesions in transgenic mice is likely to be the consequence of excess production by macrophages of toxic products such as interleukin 1, tumor necrosis factor, plasminogen activator, or -interferon, since this production is known to be stimulated by GM-CSF (2) (3) (4) (5) .
Such a postulated mechanism fails to account satisfactorily for the lesions in transgenic mice where the two lines diverge significantly. The present studies have shown that the two lines differ significantly in their mortality rates, in the frequency and severity of skeletal muscle and gut lesions, and in the frequency of spleen enlargement and atrophy. The most dramatic differences are the development in a significant proportion of male-line transgenic mice of blood-stained ascites, erythrophagocytosis by peritoneal macrophages, and nodular lesions in the abdominal and pleural cavity-lesions never observed in female-line transgenic mice.
These interline differences could in principle be based on insertional cis-acting effects influencing the transcription of the transgene or adjacent cellular genes. The similar GM-CSF levels in the two lines argue against a major effect on the transgene. However, the variety of the differences involved raises doubts as to whether all could be ascribable to a mechanism that might reasonably only affect the function of a relatively small number of adjacent genes. In view of the likely central role of the macrophage in lesion development, the most striking observation in these comparative studies was that the macrophages in the two transgenic lines differ sharply in morphology. The various differences exhibited by the two lines might therefore possibly be ascribable to a single mechanism-morphological and functional differences in macrophages dependent on the chromosomal insertion site of the GM-CSF transgenes.
It will require careful analytical studies on each type of lesion to establish the exact mechanisms involved and why a particular tissue is selected as the target of such damage. If GM-CSF-stimulated macrophages play a central role in lesion development, it is of special interest that the development of ascites with evidence of chronic bleeding was clearly associated with the presence of unusually large numbers of peritoneal macrophages. Production by the macrophages of plasminogen activator might be responsible for the bleeding into the abdominal cavity (12) . Since tumor necrosis factor can cause gut congestion and hemorrhage (13) , production of this factor by transgenic macrophages might be the mechanism involved in the gut lesions in transgenic mice. The slow leakage of erythrocytes into the peritoneal cavity of male-line mice may trigger nodule formation since fibrotic responses develop in sites of local hemorrhage-e.g., the ovarian follicle after shedding of an ovum.
The differences between the lesions developing in the two transgenic lines would predict that the morphologically different transgenic macrophages in the two lines may produce different levels of their potentially toxic products, and this needs verification using either functional assays or in situ hybridization. The GM-CSF transgenic macrophages could therefore represent a powerful tool for investigating the molecular mechanisms that could achieve diverse differences in the behavior of a single cell type based on a difference in chromosomal insertion site of the GM-CSF transgene.
